Works about PEPTIDE receptors


Results: 1738
    1

    Evaluating prediction of short‐term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population‐based study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4320, doi. 10.1111/dom.16470
    By:
    • Cardoso, Pedro;
    • Young, Katie G.;
    • Hopkins, Rhian;
    • Mateen, Bilal A.;
    • Pearson, Ewan R.;
    • Hattersley, Andrew T.;
    • McKinley, Trevelyan J.;
    • Shields, Beverley M.;
    • Dennis, John M.;
    • Hattersley, Andrew;
    • Pearson, Ewan;
    • Jones, Angus;
    • Shields, Beverley;
    • Dennis, John;
    • Rodgers, Lauren;
    • Henley, William;
    • McDonald, Timothy;
    • Weedon, Michael;
    • Britten, Nicky;
    • Angwin, Catherine
    Publication type:
    Article
    2
    3
    4

    GLP- 1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2025, v. 486, n. 6, p. 1317, doi. 10.1007/s00428-025-04098-2
    By:
    • Watanabe, Hirofumi;
    • Fujishima, Fumiyoshi;
    • Yamazaki, Yuto;
    • Imamura, Masayuki;
    • Hijioka, Susumu;
    • Hara, Kazuo;
    • Kuwahara, Takamichi;
    • Yatabe, Yasushi;
    • Sakamoto, Kazuhiro;
    • Shiga, Hisashi;
    • Kawaguchi, Tomohiro;
    • Suzuki, Hiroyoshi;
    • Kanbayashi, Yumi;
    • Ohkoshi, Akira;
    • Shimada, Muneaki;
    • Niikawa, Hiromichi;
    • Sato, Mami;
    • Fujio, Atsushi;
    • Masui, Toshihiko;
    • Kasai, Yosuke
    Publication type:
    Article
    5
    6
    7

    A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction Open Access.

    Published in:
    Cardiovascular Research, 2025, v. 121, n. 6, p. 871, doi. 10.1093/cvr/cvaf031
    By:
    • Papworth, Monika;
    • Kulkarni, Spoorthy;
    • Antonsson, Madeleine;
    • Sermadiras, Isabelle;
    • Hovdal, Daniel;
    • Connolly, Kathleen;
    • Olsson, Jan;
    • Shukla, Animesh;
    • Cotton, Peter;
    • Althage, Magnus;
    • Paterson, Judy;
    • Martin, Esther;
    • Wolny, Marcin;
    • Ferraro, Franco;
    • Sadowska, Agnieszka;
    • Hao, Weidong;
    • Larsson, Niklas;
    • Backmark, Anna;
    • Marlow, Tom;
    • Perez, Rosario
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATE.

    Published in:
    European Radiology, 2024, v. 34, n. 11, p. 7222, doi. 10.1007/s00330-024-10788-3
    By:
    • Ebner, R.;
    • Lohse, A.;
    • Fabritius, M. P.;
    • Rübenthaler, J.;
    • Wängler, C.;
    • Wängler, B.;
    • Schirrmacher, R.;
    • Völter, F.;
    • Schmid, H. P.;
    • Unterrainer, L. M.;
    • Öcal, O.;
    • Hinterberger, A.;
    • Spitzweg, C.;
    • Auernhammer, C. J.;
    • Geyer, T.;
    • Ricke, J.;
    • Bartenstein, P.;
    • Holzgreve, A.;
    • Grawe, F.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4909, doi. 10.3390/jcm10214909
    By:
    • Gauthé, Mathieu;
    • Sargos, Paul;
    • Barret, Eric;
    • Fromont-Hankard, Gaëlle;
    • Beauval, Jean-Baptiste;
    • Brureau, Laurent;
    • Créhange, Gilles;
    • Renard-Penna, Raphaële;
    • Dariane, Charles;
    • Fiard, Gaëlle;
    • Mathieu, Romain;
    • Roubaud, Guilhem;
    • Ruffion, Alain;
    • Rouprêt, Morgan;
    • Ploussard, Guillaume
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3213, doi. 10.3390/jcm9103213
    By:
    • Vedtofte, Louise;
    • Bahne, Emilie;
    • Foghsgaard, Signe;
    • Bagger, Jonatan I.;
    • Andreasen, Camilla;
    • Strandberg, Charlotte;
    • Gørtz, Peter M.;
    • Holst, Jens J.;
    • Grønbæk, Henning;
    • Svare, Jens A.;
    • Clausen, Tine D.;
    • Mathiesen, Elisabeth R.;
    • Damm, Peter;
    • Gluud, Lise L.;
    • Knop, Filip K.;
    • Vilsbøll, Tina
    Publication type:
    Article
    46
    47
    48
    49
    50